Baraclude 1mg Entecavir Tablets

Get a Price/Quote

Baraclude 1mg Entecavir Tablets Trade Information

Minimum Order Quantity
10000000 Pieces

Payment Terms
Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)

Supply Ability
10000 Pieces Per Week

Delivery Time
2 Week

Packaging Details
30 ML

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Certifications
WHO GMP COA FSC

About Baraclude 1mg Entecavir Tablets

Baraclude - BARACLUDE is the tradename for Baraclude, a guanosine nucleoside analogue with selective activity against hepatitis B virus (HBV). Baraclude (entecavir) is indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.

This indication is based on histologic, virologic, biochemical, and serologic responses after one year of treatment in nucleoside-treatment-naive and lamivudine-resistant adult patients with HBeAg-positive or HBeAg-negative chronic HBV infection with compensated liver disease and on more limited data in adult patients with HIV/HBV co-infection who have received prior lamivudine therapy. Active ingredients: Entecavir

Tell us about your requirement